KR102272901B1 - Composition for external application to the skin containing meso-2,3-butanediol as a preservative - Google Patents

Composition for external application to the skin containing meso-2,3-butanediol as a preservative Download PDF

Info

Publication number
KR102272901B1
KR102272901B1 KR1020140142818A KR20140142818A KR102272901B1 KR 102272901 B1 KR102272901 B1 KR 102272901B1 KR 1020140142818 A KR1020140142818 A KR 1020140142818A KR 20140142818 A KR20140142818 A KR 20140142818A KR 102272901 B1 KR102272901 B1 KR 102272901B1
Authority
KR
South Korea
Prior art keywords
butanediol
composition
skin
preservative
external application
Prior art date
Application number
KR1020140142818A
Other languages
Korean (ko)
Other versions
KR20160046639A (en
Inventor
백흥수
우병영
유세진
주영협
신송석
오미현
이존환
Original Assignee
지에스칼텍스 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 지에스칼텍스 주식회사 filed Critical 지에스칼텍스 주식회사
Priority to KR1020140142818A priority Critical patent/KR102272901B1/en
Priority to US15/518,428 priority patent/US10525017B2/en
Priority to ES15853159T priority patent/ES2836746T3/en
Priority to CN201580055329.0A priority patent/CN106794122B/en
Priority to PCT/KR2015/011120 priority patent/WO2016064180A1/en
Priority to EP15853159.0A priority patent/EP3195851B1/en
Priority to JP2017521242A priority patent/JP6976169B2/en
Publication of KR20160046639A publication Critical patent/KR20160046639A/en
Priority to JP2020109587A priority patent/JP7003186B2/en
Application granted granted Critical
Publication of KR102272901B1 publication Critical patent/KR102272901B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/524Preservatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70Biological properties of the composition as a whole
    • A61K2800/72Hypo-allergenic

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

본 발명은 2,3-부탄디올의 이성질체인 하기 화학식 1로 표현되는 메조(meso)-2,3-부탄디올을 함유함으로써 화학 방부제를 포함하지 않으면서도 방부력이 우수하고 피부에 대한 자극이 적어 사용감이 뛰어난 피부 외용제 조성물에 관한 것이다.
[화학식 1]

Figure 112014100549738-pat00007
The present invention contains meso-2,3-butanediol, which is an isomer of 2,3-butanediol, represented by the following formula (1), so that it has excellent preservative power and less irritation to the skin without including a chemical preservative. It relates to an excellent composition for external application to the skin.
[Formula 1]
Figure 112014100549738-pat00007

Description

메조-2,3-부탄디올을 방부제로서 함유하는 피부 외용제 조성물{Composition for external application to the skin containing meso-2,3-butanediol as a preservative}Composition for external application to the skin containing meso-2,3-butanediol as a preservative {Composition for external application to the skin containing meso-2,3-butanediol as a preservative}

본 발명은 2,3-부탄디올의 이성질체인 메조(meso)-2,3-부탄디올을 함유함으로써 화학 방부제를 포함하지 않으면서도 방부력이 우수하고 피부에 대한 자극이 적어 사용감이 뛰어난 피부 외용제 조성물에 관한 것이다.
The present invention relates to a composition for external application for skin that contains meso-2,3-butanediol, which is an isomer of 2,3-butanediol, and has excellent preservative power without containing chemical preservatives and has less irritation to the skin and thus has excellent feeling of use will be.

피부 외용제 조성물은, 제조 과정에서 발생될 수 있는 미생물에 의한 오염, 사용 중 손가락 등의 피부 접촉에 의한 균의 오염, 또는 사용 중 물에 의한 오염 등과 같은 다양한 경로를 통해 미생물에 오염될 수 있다. 따라서, 조성물 내의 미생물의 증식을 억제 내지 사멸시키고, 제품의 보존성을 향상시키기 위하여 방부제 등의 배합이 요구된다. The composition for external application for skin may be contaminated with microorganisms through various routes such as contamination by microorganisms that may be generated during the manufacturing process, contamination of bacteria by skin contact such as fingers during use, or contamination by water during use. Therefore, in order to inhibit or kill the growth of microorganisms in the composition, and to improve the preservation of the product, the formulation of a preservative or the like is required.

일반적으로 사용되는 방부제로는, 예를 들어, 파라옥시안식향산에스테르('파라벤류'로 통칭되고 있음), 이미다졸리디닐우레아, 페녹시에탄올 또는 클로로페네신 등이 있다. 이러한 화학 방부제들은, 피부 외용제 조성물에서 사용하는 방부수단으로서는 유효성을 나타낼 수 있다. 그러나, 조성물 내에 배합된 이러한 화학 방부제들은, 피부 자극, 알러지 등을 나타낼 수 있으며, 심한 경우에는 피부 독성을 나타내기도 한다.Commonly used preservatives include, for example, paraoxybenzoic acid esters (collectively referred to as 'parabens'), imidazolidinylurea, phenoxyethanol or chlorophenesin. These chemical preservatives may exhibit effectiveness as a preservative used in the composition for external application for skin. However, these chemical preservatives formulated in the composition may exhibit skin irritation, allergies, and the like, and in severe cases may also exhibit skin toxicity.

파라벤류 또는 페녹시에탄올 등의 방부제를 배합하지 않은 피부 외용제 조성물을 제조하는 것도 가능하나, 이러한 경우에는 방부력을 확보하기 위한 별도의 조치 내지 장치가 요구된다. 예를 들어, 무균 제조하거나, 내용량이나 사용기간을 제한할 수 있으며, 경우에 따라서는 조금씩 나눠 담은 용기나 리필이 되지 않는 용기(백레스튜브, 디스펜서가 달린 용기 등)를 채용하는 등 복잡한 수단을 필요로 하여, 경제적이지 못하다는 문제점이 존재한다. It is also possible to prepare a composition for external application for skin that does not contain preservatives such as parabens or phenoxyethanol. For example, aseptic manufacturing, internal content or usage period can be limited, and in some cases, complicated means such as small portions or non-refillable containers (bagless tubes, containers with dispensers, etc.) are employed. Therefore, there is a problem that it is not economical.

한편, 일부 디올(diol)류의 방부력이 알려져 있으며, 예를 들어, 1,2-부탄디올, 1,2-헥산디올의 경우에는 방부력이 우수하여 부분적으로 사용되기도 한다. 그러나 1,2-부탄디올, 1,2-헥산디올은 피부 자극, 자극감 등 안전성의 문제로 인하여 화장료 등 외용제의 보존 용도로의 사용이 제한적인 상황이다.
On the other hand, the preservative power of some diols is known. For example, in the case of 1,2-butanediol and 1,2-hexanediol, they are partially used due to their excellent preservative power. However, the use of 1,2-butanediol and 1,2-hexanediol for the preservation of external preparations such as cosmetics is limited due to safety issues such as skin irritation and irritation.

국내 특허공개 10-2003-0026065호(2003년 3월 31일 공개)Korean Patent Publication No. 10-2003-0026065 (published on March 31, 2003)

이에 본 발명자들은 자극이 높아 피부에 대하여 안전성이 떨어지는 화학 방부제를 대체할 수 있는 물질을 찾고자 하였으며, 메조-2,3-부탄디올이 우수한 방부력을 가지면서, 피부에 대한 자극성이 낮다는 것을 발견하여 본 발명을 완성하게 되었다.Accordingly, the present inventors tried to find a material that can replace chemical preservatives with high irritation and poor safety for the skin, and found that meso-2,3-butanediol has excellent preservative power and low irritation to the skin. The present invention has been completed.

따라서, 본 발명의 목적은 방부력이 높아 기존의 화학 방부제를 대체할 수 있으면서, 피부에 대한 안전성 및 사용감이 높은 방부제 성분을 포함하는 피부 외용제 조성물을 제공하는 것이다.
Accordingly, it is an object of the present invention to provide a composition for external application for skin including a preservative component having high preservative power, which can replace conventional chemical preservatives, and has high safety and feeling of use for the skin.

상기한 목적을 달성하기 위하여, 본 발명은 하기 화학식 1로 표현되는 메조-2,3-부탄디올을 함유하는 피부 외용제 조성물을 제공한다.In order to achieve the above object, the present invention provides a composition for external application for skin containing meso-2,3-butanediol represented by the following formula (1).

Figure 112014100549738-pat00001
Figure 112014100549738-pat00001

본 발명에 따른 메조-2,3-부탄디올을 함유하는 피부 외용제 조성물은, 기존의 자극이 높아 피부에 대한 안전성이 떨어지는 화학 방부제를 사용하지 않고서도 충분한 방부력을 나타내며, 동시에 피부에 대한 안정성 및 사용감이 우수하다는 장점이 있으며, 따라서 화장료 분야 등에서 다양하게 활용 가능하다.
The composition for external application for skin containing meso-2,3-butanediol according to the present invention exhibits sufficient preservative power without the use of chemical preservatives, which have low safety for the skin due to high irritation, while at the same time providing stability to the skin and feeling of use. It has the advantage of being excellent, and therefore it can be used in various ways in the cosmetic field.

본 발명은 메조-2,3-부탄디올을 함유하는 피부 외용제 조성물을 제공한다.The present invention provides a composition for external application for skin containing meso-2,3-butanediol.

2,3-부탄디올은 일반적으로 발효에 의해 생산되는 것으로서, Klebsiella pneumoniae, Bacillus polymyxa, Enterobacter aerogenes 등의 박테리아에 의해 생산되기도 하고, 펜토스(Pentoses), 자일로스(Xylose) 및 아라비노스(Arabinose) 등을 원료로 하여 화학적으로 합성되기도 한다. 2,3-butanediol is generally produced by fermentation, Klebsiella pneumoniae , Bacillus It is produced by bacteria such as polymyxa and Enterobacter aerogenes, and is also chemically synthesized using pentoses, xylose, and arabinose as raw materials.

특히, 화장품 등의 외용제에서 2,3-부탄디올은 통상적으로 피부연화제(emollient), 보습제(humectants) 또는 습윤제(wetting agent) 등의 성분으로 조성물에 포함되어 사용되어 왔다.In particular, in external preparations such as cosmetics, 2,3-butanediol has been conventionally used as a component such as an emollient, humectants or wetting agent in the composition.

2,3-부탄디올은 입체 화학적으로 보면 세가지 이성질체들로 구분할 수 있다. 즉, 메조(Meso)-2,3-부탄디올, S,S-2,3-부탄디올, R,R-2,3-부탄디올로 구분할 수 있으며, 이들 각각의 구조는 하기 화학식 1 내지 3에 나타내어져 있다.2,3-butanediol can be classified into three isomers stereochemically. That is, it can be divided into meso-2,3-butanediol, S,S-2,3-butanediol, and R,R-2,3-butanediol, and their respective structures are shown in Formulas 1 to 3 below, have.

[화학식 1][Formula 1]

Figure 112014100549738-pat00002
Figure 112014100549738-pat00002

Figure 112014100549738-pat00003
Figure 112014100549738-pat00003

Figure 112014100549738-pat00004
Figure 112014100549738-pat00004

이러한 2,3-부탄디올의 3가지 입체 이성질체 중에서, 특히 메조-2,3-부탄디올은 다른 입체 이성질체에 비하여 방부력은 더 우수하면서, 자극성은 더 낮다는 특성을 가진다.Among these three stereoisomers of 2,3-butanediol, meso-2,3-butanediol, in particular, has better antiseptic properties and lower irritation compared to other stereoisomers.

따라서, 본 발명에 따른 조성물은 화학 방부제의 대안으로서 항균력이 있는 메조-2,3-부탄디올을 방부제로서 사용함으로써 기존에 파라벤류, 이미다졸리디닐우레아, 페녹시 에탄올 등의 화학 방부제, 및 1,2-부탄디올, 1,2-헥산디올 등의 디올류를 사용한 조성물에 비하여 자극감이 적은 조성물을 제공할 수 있다. 또한, 원하는 사용 용도에 따라 메조-2,3-부탄디올의 배합량을 조절하여, 화학 방부제를 전혀 배합하지 않고도 충분한 방부성 및 보존력을 확보할 수 있으며, 특히 화장료에 사용될 경우 피부에 대한 안전성 및 사용성이 우수하고, 화장료의 다른 성분과의 친화성도 더 뛰어나다.Therefore, the composition according to the present invention uses meso-2,3-butanediol, which has antibacterial activity, as a preservative as an alternative to chemical preservatives, so that chemical preservatives such as parabens, imidazolidinyl urea, phenoxy ethanol, and 1, It is possible to provide a composition with less irritation than a composition using diols such as 2-butanediol and 1,2-hexanediol. In addition, by adjusting the blending amount of meso-2,3-butanediol according to the intended use, sufficient antiseptic properties and preservative power can be secured without any chemical preservatives. In particular, when used in cosmetics, it is excellent in safety and usability for the skin. And it has better compatibility with other ingredients of cosmetics.

본 발명에 있어서, "피부 외용제 조성물"이란, 일반적으로 피부 외용에 사용하는 조성물 전반을 포괄하는 개념으로서, 예를 들어, 기초 화장료, 메이크업 화장료, 모발용 화장료(바디제품 포함) 등의 각종 화장료; 또는 연고제 등의 다양한 의약품 내지는 의약부외품 등으로 폭넓게 적용 가능한 조성물을 말하며, 본 발명은 이들 형태의 외용 조성물을 개별적으로 제공하는 것이다. In the present invention, "composition for external application to the skin" is a concept that encompasses the overall composition used for external application to the skin, and includes, for example, various cosmetics such as basic cosmetics, makeup cosmetics, and hair cosmetics (including body products); Or it refers to a composition that can be widely applied to various pharmaceuticals such as ointments or quasi-drugs, and the present invention is to individually provide these types of external compositions.

본 발명에 있어서, "방부"란, 제품 내 박테리아, 곰팡이 및 효모 등의 오염 미생물이 번식하여 제품을 오염시킴으로써 물질이 변질되는 현상을 막아 장기간 조성물이 안정적으로 보존될 수 있게 하는 것을 의미하며, "방부력"이란, 이들 오염 미생물 등의 주위 오염원으로부터 제품이 오염되고 이에 의하여 물질이 변질되는 것을 방지하는 능력을 의미하는 것이다. In the present invention, "preservative" means that the product can be stably preserved for a long period of time by preventing the material from being deteriorated by the proliferation of contaminating microorganisms such as bacteria, mold and yeast in the product to contaminate the product, The term "preservative power" refers to the ability to prevent the product from being contaminated by surrounding contaminants such as these contaminating microorganisms and thereby preventing the material from being deteriorated.

본 발명에 있어서, 피부 외용제 조성물에 효과적인 방부력을 유효하게 발휘시키기 위해서, 메조-2,3-부탄디올은 조성물 총 중량을 기준으로 0.001중량% 이상, 바람직하게는 0.5중량% 이상, 구체적으로는 1.0중량% 이상, 더 바람직하게는 1.5중량% 이상의 비율로 배합될 수 있다. 또한, 피부 외용제 조성물 내의 다른 성분들의 유효 함량으로서의 배합 및 메조-2,3-부탄디올의 배합에 따른 효율성을 고려하여, 메조-2,3-부탄디올의 함량은 20중량% 이하, 또는 10중량% 이하, 더 바람직하게는 4중량% 이하로 제한될 수 있다.In the present invention, in order to effectively exert an effective preservative power in the composition for external application for skin, meso-2,3-butanediol is 0.001% by weight or more, preferably 0.5% by weight or more, specifically 1.0 based on the total weight of the composition. It may be formulated in a proportion of at least 1.5 wt%, more preferably at least 1.5 wt%. In addition, in consideration of the effectiveness of the formulation as an effective content of the other components in the composition for external application for skin and the formulation of meso-2,3-butanediol, the content of meso-2,3-butanediol is 20 wt% or less, or 10 wt% or less , more preferably, it may be limited to 4% by weight or less.

본 발명의 조성물에 사용되는 메조-2,3-부탄디올은, 통상의 공지 방법을 통해 제조되어 외용제 조성물 내에 배합될 수 있으며, 시판품을 외용제 조성물 내에 배합하는 것도 가능하다.The meso-2,3-butanediol used in the composition of the present invention may be prepared through a conventionally known method and blended in the composition for external application, and a commercially available product may be blended in the composition for external application.

본 발명에 있어서의 외용제 조성물은, 상기한 본 발명의 소기의 효과만을 고려할 때에는 굳이 다른 항균제나 방부제를 본 발명 외용제 조성물 안에 추가 배합할 필요는 없지만, 상기 효과를 해치지 않는 범위에서 외용제 조성물에 통상 사용되는 다른 항균제를 본 발명 외용 조성물 속에 추가 배합하는 것도 무방하다. 또한, 본 발명 조성물에서는, 상기 소기의 효과를 저해시키지 않는 한, 외용제 조성물의 성질에 따라 통상 외용제에 배합되고 있는 성분, 예를 들면, 보습제, 자외선 흡수제, 비타민류, 동식물 추출 성분, 소화제, 미백제, 혈관확장제, 수렴제, 청량제, 호르몬제 등을 배합하는 것이 가능하다.The composition for external use in the present invention does not need to additionally blend other antibacterial agents or preservatives in the composition for external application of the present invention when only the desired effect of the present invention is considered, but is usually used in the composition for external application within a range that does not impair the above effects It is also ok to additionally mix other antibacterial agents to be used in the composition for external use of the present invention. In addition, in the composition of the present invention, as long as it does not impair the desired effect, the ingredients normally formulated in external preparations according to the properties of the external composition composition, for example, moisturizing agents, ultraviolet absorbers, vitamins, animal and plant extracts, digestive agents, whitening agents , it is possible to mix vasodilators, astringents, cooling agents, hormones, and the like.

본 발명의 피부 외용제 조성물은 화장료 조성물, 약학 조성물 등일 수 있다. 또한, 상기 조성물은 예를 들어, 유연화장수, 수렴화장수, 영양화장수, 아이 크림, 영양 크림, 마사지 크림, 클렌징 크림, 클렌징 폼, 클렌징 워터, 파우더, 에센스 또는 팩 등의 형태로 제형화될 수 있으며, 그 제형이 특별히 한정되는 것은 아니다. 또한, 각각의 제형에 있어서, 다른 성분들은 기타 조성물의 종류 또는 사용목적 등에 따라 당업자가 어려움 없이 적의 선정하여 배합할 수 있다.
The composition for external application for skin of the present invention may be a cosmetic composition, a pharmaceutical composition, or the like. In addition, the composition may be formulated in the form of, for example, softening lotion, astringent lotion, nourishing lotion, eye cream, nourishing cream, massage cream, cleansing cream, cleansing foam, cleansing water, powder, essence or pack. , the formulation is not particularly limited. In addition, in each formulation, other components may be appropriately selected and formulated by those skilled in the art without difficulty depending on the type or purpose of use of other compositions.

이하, 본 발명의 바람직한 시험예 등을 통해 본 발명을 더욱 상술하지만, 하기 시험예 등은 본 발명의 효과를 예시적으로 확인하기 위한 것이며, 본 발명의 범주가 이들만으로 한정되는 것은 아니다.
Hereinafter, the present invention will be described in more detail through preferred test examples of the present invention, but the following test examples and the like are for exemplarily confirming the effects of the present invention, and the scope of the present invention is not limited thereto.

[제형예 1~4 및 비교제형예 1~4] 영양화장수(로션류)[Formulation Examples 1-4 and Comparative Formulation Examples 1-4] Nutrient lotion (lotions)

하기 표 1의 조성에 따라 통상적인 방법으로 메조-2,3-부탄디올을 함유한 제형예 1 내지 9, 및 메조-2,3-부탄디올을 넣지 않거나(비교제형예 1), 대신에 기존 1,2-헥산디올(비교제형 2,3)이나 통상의 화학방부제인 메틸파라벤(비교제형예 4)을 넣은 비교제형예 1 내지 4의 시료를 준비하였다.Formulation Examples 1 to 9 and meso-2,3-butanediol containing meso-2,3-butanediol in a conventional manner according to the composition of Table 1 below, and no meso-2,3-butanediol (Comparative Formulation Example 1), or instead of conventional 1, Samples of Comparative Formulation Examples 1 to 4 were prepared in which 2-hexanediol (Comparative Formulations 2 and 3) or methylparaben (Comparative Formulation Example 4), which is a conventional chemical preservative, was added.

원료명Raw material name 제형예Formulation example 비교제형예Comparative formulation example 1One 22 33 44 55 66 77 88 99 1One 22 33 44 정제수Purified water 잔량remaining amount 잔량remaining amount 잔량remaining amount 잔량remaining amount 잔량remaining amount 잔량remaining amount 잔량remaining amount 잔량remaining amount 잔량remaining amount 잔량remaining amount 잔량remaining amount 잔량remaining amount 잔량remaining amount 유동파라핀liquid paraffin 5.05.0 5.05.0 5.05.0 5.05.0 5.05.0 5.05.0 5.05.0 5.05.0 5.05.0 5.05.0 5.05.0 5.05.0 5.05.0 글리세린glycerin 5.05.0 5.05.0 5.05.0 5.05.0 5.05.0 5.05.0 5.05.0 5.05.0 5.05.0 5.05.0 5.05.0 5.05.0 5.05.0 세틸옥타노에이트cetyloctanoate 5.05.0 5.05.0 5.05.0 5.05.0 5.05.0 5.05.0 5.05.0 5.05.0 5.05.0 5.05.0 5.05.0 5.05.0 5.05.0 농글리세린concentrated glycerin 3.03.0 3.03.0 3.03.0 3.03.0 3.03.0 3.03.0 3.03.0 3.03.0 3.03.0 3.03.0 3.03.0 3.03.0 3.03.0 시클로메치콘cyclomethicone 2.02.0 2.02.0 2.02.0 2.02.0 2.02.0 2.02.0 2.02.0 2.02.0 2.02.0 2.02.0 2.02.0 2.02.0 2.02.0 디메치콘dimethicone 1.01.0 1.01.0 1.01.0 1.01.0 1.01.0 1.01.0 1.01.0 1.01.0 1.01.0 1.01.0 1.01.0 1.01.0 1.01.0 스테아린산stearic acid 0.80.8 0.80.8 0.80.8 0.80.8 0.80.8 0.80.8 0.80.8 0.80.8 0.80.8 0.80.8 0.80.8 0.80.8 0.80.8 세토스테아릴알콜cetostearyl alcohol 0.70.7 0.70.7 0.70.7 0.70.7 0.70.7 0.70.7 0.70.7 0.70.7 0.70.7 0.70.7 0.70.7 0.70.7 0.70.7 스테아린산글리세린Glycerin Stearate 0.60.6 0.60.6 0.60.6 0.60.6 0.60.6 0.60.6 0.60.6 0.60.6 0.60.6 0.60.6 0.60.6 0.60.6 0.60.6 트리에탄올아민triethanolamine 0.20.2 0.20.2 0.20.2 0.20.2 0.20.2 0.20.2 0.20.2 0.20.2 0.20.2 0.20.2 0.20.2 0.20.2 0.20.2 카르복시비닐폴리머Carboxyvinyl Polymer 0.150.15 0.150.15 0.150.15 0.150.15 0.150.15 0.150.15 0.150.15 0.150.15 0.150.15 0.150.15 0.150.15 0.150.15 0.150.15 에틸렌디아민초산나트륨Sodium ethylenediamine acetate 0.020.02 0.020.02 0.020.02 0.020.02 0.020.02 0.020.02 0.020.02 0.020.02 0.020.02 0.020.02 0.020.02 0.020.02 0.020.02 향료Spices 적량appropriate amount 적량appropriate amount 적량appropriate amount 적량appropriate amount 적량appropriate amount 적량appropriate amount 적량appropriate amount 적량appropriate amount 적량appropriate amount 적량appropriate amount 적량appropriate amount 적량appropriate amount 적량appropriate amount 메조-2,3-부탄디올Meso-2,3-butanediol 0.50.5 1One 1.51.5 22 33 44 55 1010 1212 -- -- -- __ 1,2-헥산디올1,2-Hexanediol -- -- -- -- -- -- -- -- -- -- 0.50.5 1One -- 메틸파라벤methylparaben -- -- -- -- -- -- -- -- -- -- -- -- 0.50.5

[시험예 1] 방부력 시험[Test Example 1] Antiseptic test

방부력을 평가하기 위하여 상기 제형예 1 내지 94 및 비교제형예 1 내지 4의 화장료 20g에 대장균(Escherichia coli; ATCC 8739), 스타필로코쿠스 아우레우스(Staphlyococcus aureus; ATCC 6538) 및 슈도모나스 애루지노사(Pseudomonas aeruginosa; ATCC 99027) 등의 혼합균액을 시료당 초기농도 106cfu(집락형성단위, colony forming unit)/g가 되도록 첨가하여 혼합하였다. 이들을 22.5℃ 항온조에서 4 주간 배양하면서, 1, 7, 14, 21 및 28일의 간격으로 각 화장료를 1g씩 취하여 생균 수를 측정하였으며, 그 결과를 하기의 표 32에 나타내었다. Escherichia coli (Escherichia) in 20 g of the cosmetics of Formulation Examples 1 to 94 and Comparative Formulation Examples 1 to 4 in order to evaluate the preservative power coli ; ATCC 8739), Staphlyococcus aureus aureus ; ATCC 6538) and Pseudomonas aeruginosa aeruginosa ; ATCC 99027) and the like were added and mixed so that the initial concentration per sample was 10 6 cfu (colony forming unit)/g. While these were cultured in a 22.5°C thermostat for 4 weeks, 1 g of each cosmetic was taken at intervals of 1, 7, 14, 21 and 28 days, and the number of viable cells was measured, and the results are shown in Table 32 below.

곰팡이의 경우에는 페니실리움 씨트리눔(Penicillium citrinum; ATCC 9849), 아스퍼질러스니거(Aspergillus niger; ATCC 16404)의 혼합균액을 시료당 초기농도 106cfu/g가 되도록 첨가하여 혼합한 후 25℃ 항온조에서 배양하면서, 7일 간격으로 변취유무와 시료표면의 균사 및 포자발생 유무를 관찰하였으며, 그 결과를 하기 표 2에 나타내었다.In the case of the fungus, Penicillium citrinum citrinum ; ATCC 9849) and Aspergillus niger (ATCC 16404) were added to an initial concentration of 10 6 cfu/g per sample, mixed, and then cultured in a thermostat at 25° C. The presence or absence of mycelium and spores on the surface was observed, and the results are shown in Table 2 below.

화장료cosmetics 박테리아(cfu/g)Bacteria (cfu/g) 곰팡이* mold * 초기균수Initial number of bacteria 1일1 day 7일7 days 14일14 days 21일21 days 28일28 days 제형예 1Formulation Example 1 1 × 106 1 × 10 6 14251425 <1000<1000 <1000<1000 <1000<1000 <1000<1000 ++ 제형예 2Formulation Example 2 1 × 106 1 × 10 6 13241324 <1000<1000 <100<100 <100<100 <10<10 -- 제형예 3Formulation Example 3 1 × 106 1 × 10 6 <1000<1000 <100<100 <10<10 <10<10 <10<10 -- 제형예 4Formulation Example 4 1 × 106 1 × 10 6 <1000<1000 <100<100 <10<10 <10<10 <10<10 -- 제형예 5Formulation Example 5 1 × 106 1 × 10 6 <100<100 <10<10 <10<10 <10<10 <10<10 -- 제형예 6Formulation Example 6 1 × 106 1 × 10 6 <10<10 <10<10 <10<10 <10<10 <10<10 -- 제형예 7Formulation Example 7 1 × 106 1 × 10 6 <10<10 <10<10 <10<10 <10<10 <10<10 -- 제형예 8Formulation Example 8 1 × 106 1 × 10 6 <10<10 <10<10 <10<10 <10<10 <10<10 -- 제형예 9Formulation Example 9 1 × 106 1 × 10 6 <10<10 <10<10 <10<10 <10<10 <10<10 -- 비교제형예1Comparative Formulation Example 1 1 × 106 1 × 10 6 22002200 1000010000 40004000 35003500 <1000<1000 ++++ 비교제형예2Comparative Formulation Example 2 1 × 106 1 × 10 6 12501250 <1000<1000 <10<10 <10<10 <10<10 -- 비교제형예3Comparative Formulation Example 3 1 × 106 1 × 10 6 10001000 100100 <10<10 <10<10 <10<10 -- 비교제형예4Comparative Formulation Example 4 1 × 106 1 × 10 6 <10<10 <10<10 <10<10 <10<10 <10<10 --

- : 8주간 변취 및 균사와 포자 발생이 없고 양호- : No odor and no mycelium and spores for 8 weeks, good

+ : 4주 이내에 기벽이나 뚜껑에 곰팡이 발생+ : Mold on the wall or lid within 4 weeks

++ : 4주 이내에 변취 및 표면 일부에 곰팡이 발생++ : Odor and mold on a part of the surface within 4 weeks

+++ : 4주 이내에 변취 및 표면 전체에 곰팡이 발생
+++ : Bad odor and mold on the entire surface within 4 weeks

상기 표 2의 결과를 통하여, 메조-2,3-부탄디올을 사용한 제형예는 방부 효과를 나타낼 수 있으며, 특히 메조-2,3-부탄디올을 1.5중량% 이상의 양으로 함유할 경우(제형예 3 및 4)에는 기존의 1,2-헥산디올 방부제를 사용한 비교 제형예 2 및 3과 유사한 정도 또는 그보다 더 우수한 정도의 방부력을 나타내었으며, 메조-2,3-부탄디올을 4중량% 이상의 양으로 함유할 경우(제형예 6 내지 9)에는 기존 메틸파라벤 방부제를 사용한 비교 제형예 4와 유사한 정도의 매우 우수한 방부력을 나타낸다는 것을 확인할 수 있다.
Through the results of Table 2, the formulation example using meso-2,3-butanediol may exhibit an antiseptic effect, and in particular, when meso-2,3-butanediol is contained in an amount of 1.5 wt% or more (Formulation Example 3 and In 4), the preservative power of Comparative Formulation Examples 2 and 3 using the existing 1,2-hexanediol preservative was similar or superior to that of Comparative Formulation Examples 2 and 3, and meso-2,3-butanediol was contained in an amount of 4% by weight or more. In the case of (Formulation Examples 6 to 9), it can be confirmed that it exhibits a very good preservative power similar to that of Comparative Formulation Example 4 using the existing methylparaben preservative.

[시험예 2] 사용성(자극감) 시험[Test Example 2] Usability (irritation) test

제형예 6 및 비교제형예 1 내지 4의 시료들에 대하여 자극감을 평가하는 실험을 진행하였다. 구체적으로는, 패널 15명을 대상으로, 제형예 6 및 비교제형예 1 내지 4의 시료들을 각각 0.5ml씩을 좌우를 무작위로 바꾸어 적용하였다. 해당 시료들을 피부에 문지른 다음, '따가움' 및 '화끈거림' 등의 자극감을 평가하였고, 그 결과를 하기 표 3에 나타내었다. An experiment was conducted to evaluate the irritation with respect to the samples of Formulation Example 6 and Comparative Formulation Examples 1 to 4. Specifically, 0.5 ml of each of the samples of Formulation Example 6 and Comparative Formulation Examples 1 to 4 were applied to 15 panelists by changing the left and right sides at random. After rubbing the samples on the skin, irritants such as 'stinging' and 'burning' were evaluated, and the results are shown in Table 3 below.

<평가기준><Evaluation Criteria>

0 - 0.4 : None(없음)0 - 0.4 : None

0.4 ~ 1.0 : Slight(미미함)0.4 ~ 1.0 : Slight (insignificant)

1.1 ~ 2.0 : Moderate(보통)1.1 ~ 2.0 : Moderate

2.1 ~ 3.0 : Severe(심함) 2.1 ~ 3.0 : Severe

시험물질test substance 제형예6Formulation Example 6 비교제형예1Comparative Formulation Example 1 비교제형예2Comparative Formulation Example 2 비교제형예3Comparative Formulation Example 3 비교제형예4Comparative Formulation Example 4 따가움sting 0.190.19 0.200.20 0.320.32 0.380.38 0.920.92 화끈거림hot flashes 0.620.62 0.540.54 0.790.79 0.940.94 0.850.85 평균Average 0.410.41 0.370.37 0.560.56 0.660.66 0.890.89

상기의 표3에서 보는 바와 같이, 기존의 1,2-헥산디올을 사용한 비교제형예 2 및 3과 기존 메틸파라벤 방부제를 사용한 비교제형예 4와 비교하여, 방부제로서 더 많은 양의 메조-2,3-부탄디올을 사용한 제형예 6의 자극감 정도가 아주 낮은 것으로 나타났다.
As shown in Table 3 above, compared to Comparative Formulation Examples 2 and 3 using the existing 1,2-hexanediol and Comparative Formulation Example 4 using the existing methylparaben preservative, a larger amount of meso-2 as a preservative, It was found that the degree of irritation in Formulation Example 6 using 3-butanediol was very low.

[시험예 3] 피부 자극 시험[Test Example 3] Skin irritation test

2,3-부탄디올의 입체 이성질체인 메조(Meso)-2,3-부탄디올, S,S-2,3-부탄디올, R,R-2,3-부탄디올과 히드록시 위치가 다르지만 유사한 1,3-부탄디올, 1,2-부탄디올과 기존 사용 디올인 1,2-헥산디올의 인체에서의 피부 안전성을 평가하기 위하여 24시간 첩포시험을 수행하였다. 첩포는 피험자의 등상부에 부착하였으며, 준비된 시험물질 20μl를 IQ chamber(chemotechique, Sweeden)를 이용하여 첩포하였다. 첩포를 부착하고 24시간 경과 후 첩포를 제거하였다. 첩포를 제거한 후 30 분 후에 첫 판독을 시행하였고, 24시간이 경과한 후에 2차 판독을 시행하였다.Meso-2,3-butanediol, S,S-2,3-butanediol, and R,R-2,3-butanediol, which are stereoisomers of 2,3-butanediol, have different hydroxy positions but are similar to 1,3-butanediol A 24-hour patch test was performed to evaluate the skin safety of butanediol, 1,2-butanediol, and 1,2-hexanediol, an existing diol, in the human body. The patch was attached to the upper back of the subject, and 20 μl of the prepared test material was applied using an IQ chamber (chemotechique, Sweeden). The patch was removed after 24 hours had elapsed after the patch was applied. The first reading was performed 30 minutes after the patch was removed, and the second reading was performed after 24 hours.

시료의 피부자극의 강도를 알아보기 위해 피부의 양성반응의 정도에 따라 가중치를 부여하였으며, 피부 평균반응도를 구하여 시료의 피부 자극을 판정하였다. 피부 평균 반응도는 하기 수학식 1을 통해 산출하였으며, 판정기준은 하기 표 4와 같다. 실험 결과는 표 5에 나타내었다.In order to find out the strength of the skin irritation of the sample, weights were given according to the degree of positive skin reaction, and the skin irritation of the sample was determined by obtaining the average skin reactivity. The skin average reactivity was calculated through Equation 1 below, and the determination criteria are shown in Table 4 below. The experimental results are shown in Table 5.

Figure 112014100549738-pat00005
Figure 112014100549738-pat00005

ScoreScore 피부자극 강도skin irritation intensity 1 미만(Grade I)Less than 1 (Grade I) 무자극non-irritant 1 이상 3 미만(Grade II)1 to less than 3 (Grade II) 경자극mild stimulation 3 이상 5 미만(Grade III)3 or more and less than 5 (Grade III) 중자극central stimulus 5 이상(Grade IV)5 or higher (Grade IV) 강자극strong stimulus

시험물질test substance 함량(%)content(%) ScoreScore 정제수Purified water 100100 0.320.32 1,3-부탄디올1,3-butanediol 3030 0.520.52 1,2-부탄디올1,2-Butanediol 3030 2.482.48 S,S-2,3-부탄디올S,S-2,3-butanediol 3030 2.122.12 R,R-2,3-부탄디올R,R-2,3-butanediol 3030 1.451.45 메조-2,3-부탄디올Meso-2,3-butanediol 3030 0.410.41 1,2-헥산디올1,2-Hexanediol 2020 2.542.54

상기 표 5의 결과에서, 메조-2,3-부탄디올은 1,2-헥산디올보다 피부자극 수치가 더 낮은 것으로 나타났으며, 또한 다른 입체 이성질체인 S,S-2,3-부탄디올, R,R-2,3-부탄디올보다 피부자극 수치가 더 낮은 것으로 나타났다.
In the results of Table 5, meso-2,3-butanediol showed a lower skin irritation level than 1,2-hexanediol, and the other stereoisomers S,S-2,3-butanediol, R, It was found that the skin irritation level was lower than that of R-2,3-butanediol.

이상의 시험예 등을 통해, 본 발명에 따른 피부 외용제 조성물은 입체 화학적으로 이성질체인 메조-2,3-부탄디올을 사용함으로써, 종래의 화학방부제나 1,2-헥산디올을 사용하지 않으면서도, 방부력이 뛰어나며 동시에 종래의 화학방부제나 1,2-헥산디올보다 피부자극이나 자극감 수준이 매우 낮아 사용감이 개선된다는 장점이 있다.Through the above test examples, the composition for external application for skin according to the present invention uses meso-2,3-butanediol, which is a stereochemically isomer, without using conventional chemical preservatives or 1,2-hexanediol. This is excellent, and at the same time, the level of skin irritation or irritation is very low compared to conventional chemical preservatives or 1,2-hexanediol, and thus the feeling of use is improved.

Claims (10)

하기 화학식 1로 표현되는 메조-2,3-부탄디올을 방부제로서 함유하며,
S,S-2,3-부탄디올 또는 R,R-2,3-부탄디올은 방부제로서 함유하지 않는 피부 외용제 조성물.
[화학식 1]
Figure 112021012317304-pat00006
It contains meso-2,3-butanediol represented by the following formula (1) as a preservative,
A composition for external application to the skin that does not contain S , S -2,3-butanediol or R , R -2,3-butanediol as a preservative.
[Formula 1]
Figure 112021012317304-pat00006
제1항에 있어서, 상기 메조-2,3-부탄디올의 함량은 조성물 총 중량을 기준으로 0.001 내지 20중량%인 것을 특징으로 하는 피부 외용제 조성물.The composition for external application for skin according to claim 1, wherein the content of meso-2,3-butanediol is 0.001 to 20% by weight based on the total weight of the composition. 제2항에 있어서, 상기 메조-2,3-부탄디올의 함량은 조성물 총 중량을 기준으로 1.5 내지 4중량%인 것을 특징으로 하는 피부 외용제 조성물.The composition for external application for skin according to claim 2, wherein the content of meso-2,3-butanediol is 1.5 to 4% by weight based on the total weight of the composition. 제1항에 있어서, 상기 조성물은 메조-2,3-부탄디올을 단독 방부제로서 사용하는 피부 외용제 조성물.The composition for external application for skin according to claim 1, wherein the composition uses meso-2,3-butanediol as the sole preservative. 제1항에 있어서, 상기 조성물은 피부에 대한 자극이 적음을 특징으로 하는 피부 외용제 조성물.The composition for external application for skin according to claim 1, wherein the composition has little irritation to the skin. 제1항 내지 제5항 중 어느 한 항에 있어서, 상기 조성물은 화장료 조성물임을 특징으로 하는 피부 외용제 조성물.The composition for external application for skin according to any one of claims 1 to 5, wherein the composition is a cosmetic composition. 하기 화학식 1로 표현되는 메조-2,3-부탄디올을 포함하는 방부제로,
상기 방부제는 S,S-2,3-부탄디올 또는 R,R-2,3-부탄디올보다 피부 자극이 적은,
방부제.
[화학식 1]
Figure 112021012317304-pat00008
A preservative comprising meso-2,3-butanediol represented by the following formula (1),
The preservative is less irritating to the skin than S , S -2,3-butanediol or R , R -2,3-butanediol,
antiseptic.
[Formula 1]
Figure 112021012317304-pat00008
제 7항에 있어서,
상기 방부제는 메틸파라벤 또는 1,2-헥산디올보다 피부 자극이 적은, 방부제.
8. The method of claim 7,
The preservative is less irritating to the skin than methylparaben or 1,2-hexanediol.
제 7항 또는 제8항의 방부제를 포함하는 피부 외용제 조성물.
A composition for external application to the skin comprising the preservative of claim 7 or 8.
제 9항에 있어서, 상기 피부 외용제 조성물 총 중량을 기준으로 메조-2,3-부탄디올은 0.001 내지 20 중량%인 것을 특징으로 하는 피부 외용제 조성물.
The composition for external application for skin according to claim 9, wherein the amount of meso-2,3-butanediol is 0.001 to 20% by weight based on the total weight of the composition for external application for skin.
KR1020140142818A 2014-10-21 2014-10-21 Composition for external application to the skin containing meso-2,3-butanediol as a preservative KR102272901B1 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
KR1020140142818A KR102272901B1 (en) 2014-10-21 2014-10-21 Composition for external application to the skin containing meso-2,3-butanediol as a preservative
US15/518,428 US10525017B2 (en) 2014-10-21 2015-10-21 Composition containing meso-2,3-butanediol
ES15853159T ES2836746T3 (en) 2014-10-21 2015-10-21 Composition containing meso-2,3-butanediol
CN201580055329.0A CN106794122B (en) 2014-10-21 2015-10-21 Compositions containing meso-2, 3-butanediol
PCT/KR2015/011120 WO2016064180A1 (en) 2014-10-21 2015-10-21 Composition containing meso-2,3-butanediol
EP15853159.0A EP3195851B1 (en) 2014-10-21 2015-10-21 Composition containing meso-2,3-butanediol
JP2017521242A JP6976169B2 (en) 2014-10-21 2015-10-21 Composition containing meso-2,3-butanediol
JP2020109587A JP7003186B2 (en) 2014-10-21 2020-06-25 Composition containing meso-2,3-butanediol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020140142818A KR102272901B1 (en) 2014-10-21 2014-10-21 Composition for external application to the skin containing meso-2,3-butanediol as a preservative

Publications (2)

Publication Number Publication Date
KR20160046639A KR20160046639A (en) 2016-04-29
KR102272901B1 true KR102272901B1 (en) 2021-07-02

Family

ID=55915758

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020140142818A KR102272901B1 (en) 2014-10-21 2014-10-21 Composition for external application to the skin containing meso-2,3-butanediol as a preservative

Country Status (1)

Country Link
KR (1) KR102272901B1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018093210A2 (en) * 2016-11-18 2018-05-24 지에스칼텍스 주식회사 Cosmetic composition including 2,3-butanediol
KR20190102898A (en) * 2018-02-27 2019-09-04 지에스칼텍스 주식회사 Composition containing 2,3-butanediol as effective ingredient
KR102352050B1 (en) * 2020-04-22 2022-01-17 지에스칼텍스 주식회사 A dispersant or dispersion mediuim composition comprising 2,3-butanediol, and a cosmetic composition comprising it
KR102597745B1 (en) * 2021-04-19 2023-11-03 코스맥스 주식회사 Cosmetic composition of formulation that freezes at refrigeration temperature
KR102358611B1 (en) * 2021-07-09 2022-02-08 주식회사 엘지생활건강 Cosmetic composition for enhancing skin elasticity or improving skin wrinkle containing Polygonum Cuspidatum root exracts

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002212021A (en) * 2001-01-12 2002-07-31 Naris Cosmetics Co Ltd Cosmetic
US20110177579A1 (en) 2008-09-26 2011-07-21 Ma Kesen Thermostable Alcohol Dehydrogenase Derived From Thermococcus Guaymasensis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100439869B1 (en) 2001-09-24 2004-07-12 주식회사 태평양 Preservation agent containing 2-ethyl-1,3-hexanediol and composition for external application comprising the preservation agent
KR20120007339A (en) * 2010-07-14 2012-01-20 동우 화인켐 주식회사 Cleaning composition

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002212021A (en) * 2001-01-12 2002-07-31 Naris Cosmetics Co Ltd Cosmetic
US20110177579A1 (en) 2008-09-26 2011-07-21 Ma Kesen Thermostable Alcohol Dehydrogenase Derived From Thermococcus Guaymasensis

Also Published As

Publication number Publication date
KR20160046639A (en) 2016-04-29

Similar Documents

Publication Publication Date Title
KR102272901B1 (en) Composition for external application to the skin containing meso-2,3-butanediol as a preservative
CN111031794B (en) Antimicrobial mixture containing 4- (3-ethoxy-4-hydroxyphenyl) butan-2-one and organic acid compound, and cosmetic composition containing the same
JP7003186B2 (en) Composition containing meso-2,3-butanediol
JP6073354B2 (en) Skin preparation for external use with excellent antiseptic properties
EP3013311B1 (en) Synergistic preservative blends
KR102412958B1 (en) Antibacterial or conservative composition containing polyglycerine-3
KR101702648B1 (en) A preservative for skin external application, and a cosmetic composition and a pharmaceutical composition comprising the same
KR102093827B1 (en) Cosmetic compositions containing poly(butyl cyanoacrylate)
KR20160044071A (en) Preservative composition containing methyl 3-acetyl-4-hydroxybenzoate as an active ingredient
KR101779131B1 (en) A preservative for skin external application, and a cosmetic composition and a pharmaceutical composition comprising the same
KR20160046638A (en) Antibacterial Composition containing meso-2,3-butanediol
KR101585795B1 (en) Preservative composition containing diethylene glycol monobenzyl ether as an active ingredient
KR102394120B1 (en) Antimicrobial composition comprising alkanediol and reuterin and use thereof
KR101788179B1 (en) Low irritation skin external application composition with an improved antiseptic ability
KR20190046681A (en) Compositions containing phlorotannin for cooling skin and product thereof
JP2019210250A (en) Preservative composition containing isopentyldiol
JP2007145748A (en) Antiseptic sterilizer, cosmetic or medicine containing the antiseptic sterilizer, and method for antiseptic sterilization
KR20030026065A (en) Preservation agent containing 2-ethyl-1,3-hexanediol and composition for external application comprising the preservation agent
KR102189174B1 (en) Composition of antibacterial agent containing industrial preservatives
KR102566759B1 (en) Composition of preservatives for cosmetic and cosmetic composition comprising the same
CN111031793A (en) Antimicrobial mixture containing 4- (3-ethoxy-4-hydroxyphenyl) butan-2-one and chlorphenesin, and cosmetic composition containing the same
KR102363112B1 (en) Composition for inhibiting microbial growth comprising 1,2-hexanediol and glyceryl caprylate
KR101650391B1 (en) Low-irritant Composition for External Application to Skin containing 1,8-octanediol
KR20160094524A (en) Preservative composition containing benzyl glycol as an active ingredient
KR20230101481A (en) A preservative for skin external application, and a cosmetic composition and a pharmaceutical composition comprising the same

Legal Events

Date Code Title Description
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant